Stem Cell Therapeutics Corp President and CEO is invited to attend the panel discussion at BioFlorida’s 11th Annual Conference to be held October 19-21 at the Ritz-Carlton in Amelia Island, Florida.

Other than Moore, the conference will find Dr. Todd E. Golde, Professor and Consultant in the Department of Neuroscience at the Mayo Clinic Jacksonville as the chairman. The conference will fond other big names like Dr. Daniel Kelly, Scientific Director and Professor at the Burnham Institute for Medical Research and Dr. Dennis Steindler, Professor of Neuroscience and Neurosurgery at the University of Florida, College of Medicine.

Titled as Individualized Medicine, the conference will be focused on some issues like how discovery science is leading to individualized and personal medicine, specifically in relation to stem cell based therapies, and what the potential for translation into the commercial sector.

The 2008 BioFlorida Annual Conference on October 19-21 at The Ritz-Carlton in Amelia Island brings together leading national speakers as the state’s largest bioscience forum reaches key business and scientific leaders from all sectors of the industry.The forum provides attendees with insight into how the industry is dealing with today’s economic and political environment.

Attendees gain knowledge from distinguished speakers that include Yank D. Coble Jr., MD from University of North Florida; James C. Greenwood from the Biotechnology Industry Organization; Bob Ingram from GlaxoSmithKline; Stephen N. Oesterle, MD from Medtronic; and Jacksonville Mayor John Peyton.
To know more about the conference, please contact:
Stem Cell Therapeutics Corp.
Alan Moore, PhD
President and CEO
(403) 245-5495 ext.224

Source: Marketwire